MedElevator Войти в исследования
← Поиск публикаций

DOI 10.55563/clinexprheumatol/btj1ia

Медицинская библиотека · Clinical and experimental rheumatology · 2022

Features and risk factors for new (secondary) permanent visual involvement in giant cell arteritis.

Curumthaullee Muhammad Faiz, Liozon Eric, Dumonteil Stéphanie, Gondran Guillaume, Fauchais Anne-Laure, Ly Kim-Heang, Robert Pierre-Yves, Parreau Simon

СтатьяПеревод в очереди

Аннотация

OBJECTIVES

New permanent visual loss (PVL) in treated patients with giant cell arteritis (GCA) is a rare but worrisome occurrence. In this study, we aimed to describe the frequency and main features of new PVL occurring after the beginning of glucocorticoid therapy in patients with newly diagnosed GCA.

METHODS

We included in an inception cohort all consecutive patients newly diagnosed with GCA in the internal medicine department of a tertiary-care hospital between 1976 and May 2020. The study population comprised all the patients without bilateral PVL before treatment who were followed for at least one year. Only well-documented visual events that set after the initiation of glucocorticoid treatment were regarded as new PVL.

RESULTS

Eleven out of 502 patients (2.2%) experienced a new PVL including 6 occurrences during the initial therapeutic phase and 5 during the tapering phase. Patients with new PVL during treatment had higher mean age, more often displayed temporal artery abnormalities on physical examination, and had higher mean platelet counts at GCA onset. There was a strong excess risk of contralateral recurrence during treatment in patients with unilateral loss at GCA onset compared with patients with uncomplicated GCA (10.5% vs 1.1%, OR=10.26, p<0.001).

CONCLUSIONS

New PVL in treated GCA is a rare, but significant occurrence. Older patients and patients who already had unilateral PVL at diagnosis have higher risk of new ischaemic visual loss during treatment compared to the other patients. Close clinical, laboratory, and eye monitoring of these high-risk patients is of paramount importance.

Для цитирования: Curumthaullee Muhammad Faiz, Liozon Eric, Dumonteil Stéphanie, Gondran Guillaume, Fauchais Anne-Laure, Ly Kim-Heang, Robert Pierre-Yves, Parreau Simon. Features and risk factors for new (secondary) permanent visual involvement in giant cell arteritis.. Clinical and experimental rheumatology. 2022. DOI: 10.55563/clinexprheumatol/btj1ia.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.